DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a leading global medical products company, today announced that its Board of Directors has declared a quarterly cash dividend of $0.22 per share of common stock. The dividend is payable on Jan. 2, 2020, to shareholders of record as of Dec. 6, 2019. The indicated annual dividend rate is $0.88 per share of common stock.
About Baxter
Every day, millions of patients and caregivers rely on Baxter's leading portfolio of critical care, nutrition, renal, hospital and surgical products. For more than 85 years, we've been operating at the critical intersection where innovations that save and sustain lives meet the healthcare providers that make it happen. With products, technologies and therapies available in more than 100 countries, Baxter's employees worldwide are now building upon the company's rich heritage of medical breakthroughs to advance the next generation of transformative healthcare innovations. To learn more, visit www.baxter.com and follow us on Twitter, LinkedIn and Facebook.
More on illi News
This release includes forward-looking statements concerning Baxter's dividends and rates thereof. The statements are based on assumptions about many important factors, including the following, which could cause actual results to differ materially from those in the forward-looking statements: continued strength in the company's financial position, including cash flows; alternative uses of funds including, but not limited to dividends, share repurchases, research and development, business development transactions and other investments in the company's businesses; developments in the previously announced investigation related to foreign exchange gains and losses; and other risks identified in the company's most recent filing on Form 10-K and other SEC filings, all of which are available on Baxter's website. Baxter does not undertake to update its forward-looking statements.
Baxter is a registered trademark of Baxter International Inc.
About Baxter
Every day, millions of patients and caregivers rely on Baxter's leading portfolio of critical care, nutrition, renal, hospital and surgical products. For more than 85 years, we've been operating at the critical intersection where innovations that save and sustain lives meet the healthcare providers that make it happen. With products, technologies and therapies available in more than 100 countries, Baxter's employees worldwide are now building upon the company's rich heritage of medical breakthroughs to advance the next generation of transformative healthcare innovations. To learn more, visit www.baxter.com and follow us on Twitter, LinkedIn and Facebook.
More on illi News
- New Partner at Itero Group Signals Continued Growth
- 360Quadrants Releases Quadrant of Best Marketing Automation Software Vendors
- Chicago: Recovery Task Force Releases Advisory Report to Guide City's Planning Efforts to Recover from Covid-19
- Travel + Leisure Readers give San Miguel De Allende a reason to Celebrate as it ranks in World's Best Awards
- MULTI-FUN project aims to enable multi-materials metal additive manufacturing for complex 3D parts without size constraints
This release includes forward-looking statements concerning Baxter's dividends and rates thereof. The statements are based on assumptions about many important factors, including the following, which could cause actual results to differ materially from those in the forward-looking statements: continued strength in the company's financial position, including cash flows; alternative uses of funds including, but not limited to dividends, share repurchases, research and development, business development transactions and other investments in the company's businesses; developments in the previously announced investigation related to foreign exchange gains and losses; and other risks identified in the company's most recent filing on Form 10-K and other SEC filings, all of which are available on Baxter's website. Baxter does not undertake to update its forward-looking statements.
Baxter is a registered trademark of Baxter International Inc.
Filed Under: Business
0 Comments
Latest on illi News
- Americart 2019 Documentary Film about Art in America's Heartland now available on Amazon Prime Video
- Seismic Shift from New York to the Palm Beaches Signals Permanent Residency, Not Seasonal Vacation Homes
- 360Quadrants Releases Quadrant of Best Landing Page Builder Software Vendors
- Chicago: Mayor Lightfoot and DCASE Launch 5 Days of Virtual Events and Community Meals to Support Neighborhood Restaurants and Nonprofits
- Travel + Leisure Readers Give San Miguel De Allende a Reason to Celebrate as It Ranks In World's Best Awards
- NS4ed Partners with MetaMetrics to Offer Quantile Measures and Career Database for new Career-Focused Algebra and Geometry Curricula
- "Secret Shopper" Patients Improve Medical Care, Documentation, and Spending
- Thiel College and local Veterans of Foreign Wars post to research connections to Camp Reynolds and World War II
- Lantek reinforces its southern European presence by adding a new distributor, AlfaSolid, in Greece and Cyprus
- JNESHIA Unveils New Single "KINGZ"
- WJ Castle Awarded Underwater Inspection Contract from PEPCO Holdings
- Police Arrest Naperville Man for Possession and Distribution of Child Pornography
- Renowned economist George Kaufman passes away
- Chicago: Mayor Lightfoot and OEMC Expand Cooling Resources for Residents to Beat Extreme Heat This Week
- Electri-Flex Wins 2020 tED Magazine Best of the Best Marketing Award
- Altitude Outdoor Adventure Partners with TRYTN
- Lake Geneva Cruise Lines Comes Aboard with TRYTN
- Intermountain Healthcare Implements DeepThink Health's Precision Intelligence Solutions to Manage its Molecular Tumor Board
- "Blades Direct Reviews" Announces SHOXX and Samedia Products: BX13, Master MST, GX20 and BFM an
- Cure SMA Urges Remaining States to Expedite Adoption of Newborn Screening for Spinal Muscular Atrophy